Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An update on the PRO CURE study, which is currently in the process of setting up.

PROCURE logo

New National Surgical Shoulder Trial (PRoCuRe Trial)

Professor Jonathan Rees and colleagues in the Surgical Intervention Trials Unit (SITU) have been awarded a £1.5 million National Institute of Health Research HTA grant to explore the benefits of surgical repair of partial rotator cuff tendon tears of the shoulder.

 

Rotator cuff problems are the most common cause of shoulder pain and disability, affecting people with day to day activities, work, recreation and sleep. These tears can be full tears through the whole tendon or only partially through. Partial tears are usually treated in the NHS first with physiotherapy and a steroid injection but then surgery if patient does not get better.

 

Professor Rees, Deputy Director at the Botnar Research Centre, NDORMS says: “Surgery for full tears is one of the most common shoulder operations in the UK but for partial tears, we still don’t know  if surgical repair gives patients a better result in the short term, or whether it prevents full tears developing in the long term. UK patients and surgeons have prioritised a need to answer this question which is why this trial has been funded by the HTA”

 

The study will take place across 20 NHS hospitals in the UK, recruiting adult patients, who have partial tears of the rotator cuff tendon and persistent shoulder pain after physiotherapy and injection treatments. The randomised controlled trial will compare arthroscopic (keyhole) surgery that cleans, tidies and repairs the tear, to a procedure that just cleans and tidies the tear. The team will monitor how well patients recover firstly over 2 years and then over 5 years.

Similar stories

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.

HUSH trial opens to recruitment!

OCTRU

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Main OCTRU Trials

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.